A
A. Johnson
Researcher at Genentech
Publications - 8
Citations - 219
A. Johnson is an academic researcher from Genentech. The author has contributed to research in topics: Atezolizumab & Cancer. The author has an hindex of 3, co-authored 5 publications receiving 108 citations.
Papers
More filters
Journal ArticleDOI
Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3).
David J. Kwiatkowski,Valerie W. Rusch,Jamie E. Chaft,Bruce E. Johnson,Alan Nicholas,Ignacio I. Wistuba,Robert E. Merritt,Jay M. Lee,Paul A. Bunn,Yan Tang,S. Phan,Saiama N. Waqar,Alexander Patterson,Eric B. Haura,Eric M. Toloza,Karen L. Reckamp,Dan J. Raz,Katja Schulze,A. Johnson,David P. Carbone +19 more
TL;DR: A large multicentre trial has shown that preoperative immune checkpoint inhibitor therapy may be of benefit in early-stage NSCLC and aims to extend the scope of this study to include further studies in patients with recurrent NSCLCs.
Journal ArticleDOI
PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
Jivianne T. Lee,Jamie E. Chaft,Alan Nicholas,Alexander Patterson,S. Waqar,Eric M. Toloza,Eric B. Haura,Dan J. Raz,Karen L. Reckamp,Robert E. Merritt,Dwight H. Owen,David J. Finley,C. Mcnamee,Justin D. Blasberg,Edward B. Garon,John D. Mitchell,Robert C. Doebele,Frank A. Baciewicz,Misako Nagasaka,Harvey I. Pass,Katja Schulze,S. Phan,A. Johnson,Paul A. Bunn,Bruce E. Johnson,Mark G. Kris,David J. Kwiatkowski,I. I. Wistuba,David P. Carbone,V. Rusch +29 more
Journal ArticleDOI
OA06.06 Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study
David P. Carbone,Jivianne T. Lee,Mark G. Kris,I. I. Wistuba,David J. Kwiatkowski,Dwight H. Owen,Paul A. Bunn,Bruce E. Johnson,F. Oezkan,Y. Tang,Edwin R. Parra,Gerard Lozanski,Christopher J. Rivard,Katja Schulze,Alan Nicholas,A. Johnson,J. Grindheim,David S. Shames,S. Phan,Eric M. Toloza,Eric B. Haura,C. Mcnamee,Justin F. Gainor,Alexander Patterson,S. Waqar,Dan J. Raz,Karen L. Reckamp,David J. Finley,V. Rusch,Jamie E. Chaft,J. Abel +30 more
Journal ArticleDOI
OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3
Filiz Oezkan,Kai He,Dwight H. Owen,Maciej Pietrzak,J.H. Cho,Rhonda Kitzler,Rebecca Pearson,V. Rusch,Jamie E. Chaft,Robert D. Suh,Justin D. Blasberg,Karen L. Reckamp,Dan J. Raz,Peter J. Kneuertz,L. Fiorillo,Edward B. Garon,Alan Nicholas,A. Johnson,Katja Schulze,J. Grindheim,R. Banchereau,S. Phan,Paul A. Bunn,David J. Kwiatkowski,Bruce E. Johnson,Mark G. Kris,I. I. Wistuba,J.M. Lee,Gerard Lozanski,David P. Carbone +29 more
Journal ArticleDOI
P2.04-88 Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial
J.M. Lee,Jamie E. Chaft,Alan Nicholas,G. Patterson,S. Waqar,Eric M. Toloza,Eric B. Haura,Dan J. Raz,Karen L. Reckamp,Robert E. Merritt,Dwight H. Owen,David J. Finley,C. Mcnamee,Justin D. Blasberg,Edward B. Garon,John D. Mitchell,Robert C. Doebele,Frank A. Baciewicz,Misako Nagasaka,Harvey I. Pass,A. Johnson,S. Phan,Katja Schulze,Paul A. Bunn,Bruce E. Johnson,Mark G. Kris,David J. Kwiatkowski,I. I. Wistuba,David P. Carbone,V. Rusch +29 more